Mylan, Lannett sued over price-fixing generic hypothyroid drug levothyroxine
MLex Summary: The 1199SEIU National Benefit Fund filed an antitrust complaint against Mylan Pharmaceuticals and Lannett, alleging that the companies conspired to fix the price of generic versions of the hypothyroidism...To view the full article, register now.
Already a subscriber? Click here to view full article